Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion type Assertion NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_head.
- NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion wasGeneratedBy ECO_0000203 NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_provenance.
- NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion wasDerivedFrom befree-20140225 NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_provenance.
- NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion SIO_000772 14712212 NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_provenance.
- NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion evidence source_evidence_literature NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_provenance.
- NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_assertion description "[Strong nuclear CDC25B immunoreactivity was present in both pancreatic and metastatic cancer samples, and there was a marked increase of the percentage of positive cells in primary cancer (48.6+/-16.3%) and metastatic tissues (71.7+/-3.1%) compared to normal samples (8.3+/-1.8%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385643.RApFVIGzsta5njbftrotY4d3XTeHVFu_S0oLtgfcvi7SQ130_provenance.